drugset / Trial / NCT00770796
Statins for Prevention of Contrast Induced Nephropathy
RandomizedParallel-groupQuadruple-blindPrevention
Summary
In this randomized study the investigators wish to explore the role of pre-procedural statin therapy for the prevention of contrast induced nephropathy in patients with moderate-to-severe renal dysfunction, submitted to elective coronary or angioplasty.
Timeline
- Start
- 2006-04
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 80 mg | — |